EU acts against dumped imports of lysine + wood flooring from China
(18.7.2025) The Commission imposed definitive anti-dumping duties ranging from 47.7% to 58.2% on imports of lysine originating in the People's Republic of China. Synthetic lysine is used in animal feed, pharmaceuticals, and dietary supplements. And: The Commission has imposed anti-dumping duties of 21.3% to 36.1% on multilayered wood flooring imports from China, protecting an EU industry with over 10,000 jobs).
More: Lysine Wood
China Shortcuts: Q2 GDP and more
(17.7.2025) This episode of EU Chamber's podcast contains segments on: China second quarter GDP growth; Investment in China’s real estate market in June; China June industrial output and retail sales; and China June foreign trade data. European Commission Executive Vice President Teresa Ribera and three Commissioners met European Chamber representatives during their visit to China for the 6th EU-China High-Level Environment and Climate Dialogue on 13th and 14th July.
Podcast: here
Chinese company unveils smart laser weeding robot
(16.7.2025) Wuhan: A Chinese company has rolled out a 24/7 intelligent laser weeding robot, which it claims is potentially the country's first of its kind. According to the company, "this robot is expected to replace chemical herbicides, known as number one soil killer". Source: Xinhua + China Daily.
Article: here
"Staying in Dialogue with China": Prof. Danxia Xie about China in 2035
(14.7.2025) Listen to the recording of "The long view - 10-year outlook imagining China in 2035 as the next key modernization milestone". Danxia Xie (Associate Professor, Insitute of Economics at Tsinghua University) delivers his ideas in a webinar, hosted by CNBW member China Macro Group (webinar series "Staying in Dialogue with China").
Recording: here
Bayer extends partnership with Tsinghua University
(11.7.2025) Bayer and Tsinghua University announced the sixth phase collaboration agreement, aiming to further facilitate the translation of scientific research outcomes into drug discovery and development. Focus: oncology, cardiovascular and renal diseases, neurology and rare diseases, and immunology, accelerating cutting-edge scientific research across the pharmaceutical value chain.
More: here
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- 109
- 110
- 111
- 112
- 113
- 114
- 115
- 116
- 117
- 118
- 119
- 120
- 121
- 122
- 123
- 124
- 125
- 126
- 127
- 128
- 129
- 130
- 131
- 132
- 133
- 134
- 135
- 136
- 137
- 138
- 139
- 140
- 141
- 142
- 143
- 144
- 145
- 146
- 147
- 148
- 149
- 150
- 151
- 152
- 153
- 154
- 155
- 156
- 157
- 158
- 159
- 160
- 161
- 162
- 163
- 164
- 165
- 166
- 167
- 168
- 169
- 170
- 171
- 172
- 173
- 174
- 175